HALOG (halcinonide) by PharmaIN is corticosteroid hormone receptor agonists [moa]. First approved in 1977.
Drug data last refreshed 2d ago · AI intelligence enriched 2w ago
HALOG (halcinonide) is a topical corticosteroid solution that works as a hormone receptor agonist to reduce inflammation and immune response in skin conditions. It is applied directly to affected skin areas and has been in use since 1977. The drug is indicated for inflammatory and pruritic dermatological conditions responsive to corticosteroid therapy.
With LOE approaching and moderate competitive pressure (30), this product is in transition and likely operating with a lean, efficiency-focused team preparing for generic erosion.
Corticosteroid Hormone Receptor Agonists
Corticosteroid
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Study of the Role of Top-down Processes in Neuronal Reorganization and Recovery From Sensory Loss: an Exploratory Behavioral and Electroencephalographic Study in Cochlear-supported Deaf Patients
A Study to Evaluate Sleep Electroencephalogram (EEG) Features (Brain Activity While Sleeping) in Participants With Major Depressive Disorder (MDD)
Development of Electroencephalography (EEG) and Magnetoencephalography (MEG) Source Reconstruction With Fast Multipole Method
Distinguishing Alcohol Intoxication, Cannabis Intoxication and Co-intoxication Using Electroencephalography (EEG)
Safety and Performance Study of the Electroencephalographic Recording Device and Sound Emissions
Worked on HALOG at PharmaIN? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Working on HALOG offers limited growth trajectory given its LOE-approaching status and zero linked job openings, making it a challenging assignment for career advancement. This role is best suited for professionals focused on operational excellence, regulatory maintenance, and defending market share against generics rather than business expansion.